russ2000_2_0189|CYCN|0|total_current_assets|cash_on_hand|inventories_net|net_ppe|goodwill_and_intangible|liabilities|total_current_liabilities|total_long_term_liab|total_deposits|book_value_of_equity|retained_earnings|treasury_stock|ev_revenues|ev_earnings|ev_free_cash_flow|ev_assets|ps_ratio|pe_ratio|price_to_book_value|peg_ratio|debt_equity_ratio|dividend_yield|shareholder_yield_ttm|percent_of_shares_outstanding|receivables|payables|capital_stock|return_on_invested_capital|quality_ratio_fractile|momentum_fractile|market_beta_12_month|sustainable_growth_rate|institutional_investor_ownership_percentage|average_shares_outs_diluted|total_employee_number|eps|sga_expense|shares_outstanding|repurchase_of_capital_stock|ordinary_shares_number|payout_ratio|quick_ratio|normalized_eps|stock_buyback|effective_tax_rate|return_on_equity|net_income_ttm|revenues_ttm|dividend_per_share|revenues|gross_profit|pre_tax_income|net_income|interest_income|price|total_return_price|enterprise_value|average_volume_30|one_year_return|short_interest|forward_pe_ratio|forward_pe_ratio_1y|forward_ps_ratio|forward_ps_ratio_1y|quarterly_eps_estimates|quarterly_sales_estimates|quarterly_eps_surprise|quarterly_sales_surprise|quarterly_eps_actual|quarterly_sales_actual|sales_est_0y|sales_est_1y|price_target|consensus_recommendation|price_target_num_est|eps_est_0y|eps_est_1y|r_and_d_expense|reconciled_depreciation|interest_expense_non_operating|land_and_improvements|buildings_and_improvements|other_properties|machinery_furniture_equipment|price_next_month|price_second_month
russ2000_2_0189|CYCN|1|Cyclerion Therapeutics Inc Total Current Assets (Quarterly) (USD)|Cyclerion Therapeutics Inc Cash and Short Term Investments (Quarterly) (USD)|Cyclerion Therapeutics Inc Inventories (Quarterly) (USD)|Cyclerion Therapeutics Inc Net PP&E (Quarterly) (USD)|Cyclerion Therapeutics Inc Goodwill and Intangibles (Quarterly) (USD)|Cyclerion Therapeutics Inc Total Liabilities (Quarterly) (USD)|Cyclerion Therapeutics Inc Total Current Liabilities (Quarterly) (USD)|Cyclerion Therapeutics Inc Total Long Term Liabilities (Quarterly) (USD)|Cyclerion Therapeutics Inc Total Deposits (Quarterly) (USD)|Cyclerion Therapeutics Inc Book Value (Quarterly) (USD)|Cyclerion Therapeutics Inc Retained Earnings (Quarterly) (USD)|Cyclerion Therapeutics Inc Treasury Stock (Quarterly) (USD)|Cyclerion Therapeutics Inc EV to Revenues|Cyclerion Therapeutics Inc EV to Earnings|Cyclerion Therapeutics Inc EV to Free Cash Flow|Cyclerion Therapeutics Inc EV to Assets (Quarterly)|Cyclerion Therapeutics Inc PS Ratio|Cyclerion Therapeutics Inc PE Ratio|Cyclerion Therapeutics Inc Price to Book Value|Cyclerion Therapeutics Inc PEG Ratio|Cyclerion Therapeutics Inc Debt to Equity Ratio|Cyclerion Therapeutics Inc Dividend Yield|Cyclerion Therapeutics Inc Shareholder Yield (TTM)|Cyclerion Therapeutics Inc Percent of Shares Outstanding Short|Cyclerion Therapeutics Inc Total Receivables (Quarterly) (USD)|Cyclerion Therapeutics Inc Total Payables (Quarterly) (USD)|Cyclerion Therapeutics Inc Total Capital Stock (Quarterly) (USD)|Cyclerion Therapeutics Inc Return on Invested Capital|Cyclerion Therapeutics Inc Quality Ratio Score|Cyclerion Therapeutics Inc Momentum Score|Cyclerion Therapeutics Inc Beta (1Y)|Cyclerion Therapeutics Inc Sustainable Growth Rate (TTM)|Cyclerion Therapeutics Inc Institutional Investor Ownership Percentage|Cyclerion Therapeutics Inc Average Diluted Shares Outstanding (Quarterly)|Cyclerion Therapeutics Inc Total Employees (Annual)|Cyclerion Therapeutics Inc EPS Diluted (Quarterly) (USD)|Cyclerion Therapeutics Inc SG&A Expense (Quarterly) (USD)|Cyclerion Therapeutics Inc Shares Outstanding|Cyclerion Therapeutics Inc Repurchase of Capital Stock (Quarterly) (USD)|Cyclerion Therapeutics Inc Ordinary Shares Number (Quarterly)|Cyclerion Therapeutics Inc Payout Ratio|Cyclerion Therapeutics Inc Quick Ratio (Quarterly)|Cyclerion Therapeutics Inc Normalized Diluted EPS (Quarterly) (USD)|Cyclerion Therapeutics Inc Stock Buybacks (Quarterly) (USD)|Cyclerion Therapeutics Inc Effective Tax Rate (TTM)|Cyclerion Therapeutics Inc Return on Equity|Cyclerion Therapeutics Inc Net Income (TTM) (USD)|Cyclerion Therapeutics Inc Revenue (TTM) (USD)|Cyclerion Therapeutics Inc Dividend Per Share (Quarterly) (USD)|Cyclerion Therapeutics Inc Revenue (Quarterly) (USD)|Cyclerion Therapeutics Inc Gross Profit (Quarterly) (USD)|Cyclerion Therapeutics Inc Pre-Tax Income (Quarterly) (USD)|Cyclerion Therapeutics Inc Net Income (Quarterly) (USD)|Cyclerion Therapeutics Inc Net Interest Income (Quarterly) (USD)|Cyclerion Therapeutics Inc Price (USD)|Cyclerion Therapeutics Inc Total Return Price (USD)|Cyclerion Therapeutics Inc Enterprise Value (USD)|Cyclerion Therapeutics Inc 30-Day Average Daily Volume|Cyclerion Therapeutics Inc 1 Year Price Returns (Daily)|Cyclerion Therapeutics Inc Short Interest|Cyclerion Therapeutics Inc PE Ratio (Forward)|Cyclerion Therapeutics Inc PE Ratio (Forward 1y)|Cyclerion Therapeutics Inc PS Ratio (Forward)|Cyclerion Therapeutics Inc PS Ratio (Forward 1y)|Cyclerion Therapeutics Inc Quarterly EPS Estimates (USD)|Cyclerion Therapeutics Inc Quarterly Revenue Estimates (USD)|Cyclerion Therapeutics Inc Quarterly EPS Surprise|Cyclerion Therapeutics Inc Quarterly Revenue Surprise|Cyclerion Therapeutics Inc Quarterly Actual EPS (USD)|Cyclerion Therapeutics Inc Quarterly Actual Revenue (USD)|Cyclerion Therapeutics Inc Revenue Estimates for Current Fiscal Year (USD)|Cyclerion Therapeutics Inc Revenue Estimates for Next Fiscal Year (USD)|Cyclerion Therapeutics Inc Price Target (USD)|Cyclerion Therapeutics Inc Consensus Recommendation|Cyclerion Therapeutics Inc Price Target Num Estimates|Cyclerion Therapeutics Inc EPS Estimates for Current Fiscal Year (USD)|Cyclerion Therapeutics Inc EPS Estimates for Next Fiscal Year (USD)|Cyclerion Therapeutics Inc Research and Development Expense (Quarterly) (USD)|Cyclerion Therapeutics Inc Reconciled Depreciation (Quarterly) (USD)|Cyclerion Therapeutics Inc Non-Operating Interest Expense (Quarterly) (USD)|Cyclerion Therapeutics Inc Land and Improvements (Quarterly) (USD)|Cyclerion Therapeutics Inc Buildings and Improvements (Quarterly) (USD)|Cyclerion Therapeutics Inc Other Properties (Quarterly) (USD)|Cyclerion Therapeutics Inc Machine, Furniture & Equipment (Quarterly) (USD)||
russ2000_2_0189|CYCN|2|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|percent_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_beta|percent_USD_metric|percent_USD_metric|mil_figure_USD_metric|figure_whole_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|mil_figure_money_USD_metric|mil_figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_metric|percent_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_money_USD_price|mil_figure_money_USD_metric|figure_USD_metric|percent_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|percent_USD_per_share_metric|percent_USD_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|figure_money_USD_price|figure_USD_metric|figure_whole_USD_price|figure_money_USD_per_share_metric|figure_money_USD_per_share_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric|mil_figure_money_USD_metric||
russ2000_2_0189|CYCN|4|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|daily|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|monthly|quarterly|quarterly|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
russ2000_2_0189|CYCN|5|91.2727272727|91.2727272727||91.2727272727||91.2727272727|91.2727272727|91.2727272727||91.2727272727|91.2727272727||1.44444444444|91.3333333333|6.84615384615|91.4444444444|1.44444444444||6.92805755396||91.4444444444|1.4451962111|91.3333333333|15.2537313433|91.2727272727|91.2727272727|91.2727272727|91.3333333333||32.05|30.5|91.3333333333|30.7142857143|91.3571428571|365.5|91.3571428571|91.3571428571|33.2068965517||91.2727272727|91.3333333333|91.4444444444|91.3571428571|91.3846153846||91.3333333333|91.2727272727|91.3333333333||91.4444444444||91.3571428571|91.3571428571|91.3846153846|6.93506493506|6.93506493506|6.93506493506|6.97959183673|1.44444444444|15.2537313433|||1.44755244755|1.44841269841|109.6|121.777777778|106.5|106.5|106.5|106.5|40.9090909091|42.8571428571|56.25|42.8571428571|56.25|37.2941176471|49.6111111111|91.3571428571|91.3571428571|91.5|||91.2727272727|91.2727272727||
russ2000_2_0189|CYCN|6|11|11||11||11|11|11||11|11||477|6|156|9|477||139||9|739|6|67|11|11|11|6||20|22|6|7|14|2|14|14|29||11|6|9|14|13||6|11|6||9||14|14|13|154|154|154|147|486|67|||286|504|10|9|6|6|6|6|22|21|16|21|16|17|18|14|14|2|||11|11||
russ2000_2_0189|CYCN|7|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|quarterly|daily|quarterly|daily|daily|daily|daily|quarterly|daily|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|monthly|monthly|quarterly|monthly|quarterly|yearly|quarterly|quarterly|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|market_daily|market_daily|daily|market_daily|market_daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|daily|daily|daily|daily|daily|daily|daily|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly|quarterly||
russ2000_2_0189|CYCN|201803||||||||||||||||||||||||||||||||||27.304||-0.926|3.769||||||-0.926|||||||||-25.283|-25.283|||||||||||||||||||||||||21.514|0.356|||||||
russ2000_2_0189|CYCN|201806||||||||||||||||||||||||||||||||||27.304||-1.0907|7.53||||||-1.0907|||||||||-29.781|-29.781|||||||||||||||||||||||||22.251|0.366|||||||
russ2000_2_0189|CYCN|201809||||||||||||||||||||||||||||||||||27.304||-1.0726|7.787||||||-1.0726|||||||||-29.286|-29.286|||||||||||||||||||||||||21.499|0.34|||||||
russ2000_2_0189|CYCN|201812|0.879|||6.497||17.846|17.846|||-10.445||||||||||||||||2.781||||||||27.3045|140|-1.1318|8.45|||27.4112|||-1.1318||||-115.252|||||-30.902|-30.902|||||||||||||||||||||||||22.452|0.466||||17.753|3.494||
russ2000_2_0189|CYCN|201903|0.939|||8.815||17.525|17.473|0.052||-7.752|||||-5.6886|||||||||4.9617||5.671||||||||27.38||-1.37|10.977|27.3045||27.4017|||-1.37||||-127.35|||||-37.381|-37.381||19|19|518.7855|176037.5667||1359591||||||||||||||||||26.404|0.525||||18.477|3.57|15.23|15
russ2000_2_0189|CYCN|201906|144.693|141.03||83.084||94.313|21.916|72.397||141.19|-32.254||||-2.7914|0.7339|||1.8774|||||3.3315|1.857|8.783||||||||27.393||-1.18|8.923|27.4112||27.4112||6.5198|-1.18|-175|||-129.823|||1.628||-32.254|-32.254|0.8|11.25|11.25|308.2691|189675.2||912878|||||||||||1.628||15|3|1|-4.543|-2.495|25.759|0.825||||86.754|4.649|9.65|8.79
russ2000_2_0189|CYCN|201909|120.706|117.034||81.272||90.507|19.096|71.411||119.197|-59.572||||-2.1547|1.0295|||2.7345|||||4.4921|1.44|5.005||||||||27.434||-1|7.119|27.4684||27.4684||6.2041|-1||||-127.854|||1.398||-27.317|-27.317|0.699|14.08|14.08|245.0563|114748.4333||1233920|||||||||||1.6||15|3|1|-5.92|-2.51|22.295|0.697||||85.455|4.122|13.43|1.82
russ2000_2_0189|CYCN|201912|101.197|94.895||79.75||88.749|18.249|70.5||97.729|-85.627||||0.391|-0.1063|||0.6153|||||2.8119|1.474|3.311||||||||27.38|94|-0.95|7.385|27.5981||27.5981||5.2808|-0.95||||-123.007|||1.481||-26.055|-26.055|0.531|2.72|2.72|-43.692|900320.8||776030||||17.4189|-0.892|0.474|-6.5022|212.4473|-0.95|1.481|3.5||5|3|1|-4.949|-0.882|20.682|0.653||||82.642|4.122|3.5|4.26
russ2000_2_0189|CYCN|202003|70.126|67.096||63.854||58.49|11.435|47.055||81.54|-105.855||1.1691|-0.061|0.043|0.0461|13.1847||0.923||||-237.9318|5.4076|1.026|1.522||-96.3062||1|-0.2716|-122.5434||27.669||-0.73|6.891|27.7549||27.7549||5.9573|-0.8064|||-122.5434|-105.854|5.521||1.014||-20.228|-20.228|0.361|2.65|2.65|-4.6916|545970.9667|-87.399|1500876||||17.0671|-0.87||16.092||-0.73|1.014|||5|3|1|-2.008|-1.042|16.825|0.626||||65.589|3.779|3.53|4.29
russ2000_2_0189|CYCN|202006|59.562|56.462||62.093||61.937|15.645|46.292||66.101|-125.389||24.0599|-1.1992|-1.1205|0.8723|35.0991||2.2465||0.0531||-0.4263|3.7434|0.751|2.588||-91.4394||1|1.7626|-92.0739||27.791||-0.7|6.627|27.8577||27.8577||3.657|-0.7|||-92.0739|-93.134|4.642||0.749||-19.534|-19.534|0.138|5.91|5.91|116.0863|278370.5667|-48.3843|1042815||||38.2037|-0.863||18.8876||-0.7|0.749|||5|3|1|-2.008|-1.042|13.794|0.613||||64.156|3.808|3.6|6.71
russ2000_2_0189|CYCN|202009|70.124|66.84||54.576||56.048|16.262|39.786||75.354|-144.201||39.2853|-1.6916|-1.9863|1.0894|47.9426||3.4895||0.0466||-12.084|2.7617|0.4|1.855||-94.6762||3|2.1254|-96.1866||32.096||-0.59|8.033|33.9616||33.9616||4.1348|-0.6657|-24.25||-96.1866|-84.629|3.644||0.4||-18.812|-18.812|0.093|6.89|6.89|182.114|247361.3|-49.835|937901||||47.9143|-0.56||-5.3571||-0.59||||4|3|1|-1.76|-0.67|13.703|0.588||||56.684|3.808|2.5|2.98
russ2000_2_0189|CYCN|202012|58.501|54.395||50.267||55.885|16.952|38.933||59.493|-163.429||23.2137|-0.6851|-0.4645|0.4619|40.509||1.3476||0.059||-23.9496|1.7123|0.127|1.435||-99.5562||9|2.6644|-102.3126||34.024|34|-0.55|7.265|34.0473||34.0473||3.2163|-0.55|||-102.3126|-77.802|2.296||0.133||-19.228|-19.228|-0.004|3|3|38.2151|341817.8333|12.5|582989|||24.1756|23.9505|-0.19||-189.4737||-0.55|0.133|||4|3|1|-1.31|-1|12.092|0.47||||43.402|2.258|3.17|3.94
russ2000_2_0189|CYCN|202103|44.446|41.429||49.003||51.534|13.467|38.067||48.433|-176.828||42.6357|-0.8074|-0.5529|0.5732|66.4244||1.5432||0.0725||-26.2037|2.2541||1.095||-102.8722||2|4.2588|-107.2356||34.081||-0.39|5.365|34.1299||34.1299||3.0763|-0.39|||-107.2356|-70.973|1.344||0.062||-13.399|-13.399|-0.004|2.69|2.69|40.9234|297919.5333|5.283|769315|||22.0959|21.8902||||||||||||||8.092|0.258|0.004|||42.396|2.258|2.56|2.96
russ2000_2_0189|CYCN|202106|72.989|70.39||0.153||10.51|10.51|||65.222|-193.01||28.3428|-1.5068|-2.1242|1.3454|36.8596||3.3216||0.0538||-32.854|4.3034||1.386||-101.7935||2|3.4565|-107.4704|83.3296|35.707||-0.45|6.241|43.2752||43.2752||6.6974|-0.4253|-30.497||-107.4704|-67.621|3.595||3||-16.182|-16.182|-0.006|3.98|3.98|122.9552|2092567.7333|-34.0102|1862322|||39.1631|38.7985||||||||||||||12.054|0.118|0.006||||2.258|3.24|3.42
russ2000_2_0189|CYCN|202109|63.682|62.503||1.561||11.355|11.355|||56.387|-204.3||20.8772|-1.2308|-1.5642|1.0919|31.8661||2.2029||0.0622||-22.9411|2.6738|0.158|1.174||-93.1958||1|2.576|-98.5588|81.6016|43.291||-0.26|4.601|43.3101||43.3101||5.5184|-0.26|-0.006||-98.5588|-60.099|3.543||0.348||-11.29|-11.29|-0.005|3.32|3.32|76.7976|358406.5333|-49.5066|1158032|||30.8532|30.566|-0.29|1.5|10.3448|-76.8|-0.26|0.348|3.062|6|7|1|1||-0.81|7.032|0.048|0.005|||1.449|2.265|2.72|2.18
russ2000_2_0189|CYCN|202112|||||||||||||4.3774||-0.2044||17.8533||1.1984|||||1.4425||||||2|-1.8097||80.8289||||||||||||||||||||||1.56|1.56|8.5785|464775.5667|-43.7908|624842|||17.1271|16.0318|-0.32|0.9|||||||||||||||||||1.24|1.02
russ2000_2_0189|CYCN|202203|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.33|1.15||||||||||||||||||||
russ2000_2_0189|CYCN|202206|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.25|1.15||||||||||||||||||||
russ2000_2_0189|CYCN|202209|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.26|1.15||||||||||||||||||||
russ2000_2_0189|CYCN|202212|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||-0.29|0.9||||||||||||||||||||